SUBSCRIBE
SUBSCRIBE

Postmarket research

Drug Development
Estrogen Pills Can Benefit Women With Metastatic Breast Cancer, Washington University School of Medicine Study
December 12, 2008
 · 
1 min read
Drug Development
Certain Chemotherapy Combinations Work Best, University of Ioannina School of Medicine Study
December 10, 2008
 · 
1 min read
Drug Development
Statins Do Not Interfere With Rituximab Treatment For Lymphomas, Mayo Clinic Study Finds
December 9, 2008
 · 
1 min read
Drug Development
National Institutes of Health (NIH) Release: Hepatitis C Treatment Reduces The Virus But Liver Damage Continues
December 8, 2008
 · 
3 min read
Drug Development
National Institutes of Health (NIH) Release: Hepatitis C Treatment Reduces The Virus But Liver Damage Continues
December 5, 2008
 · 
3 min read
Drug Development
Extended Drug Therapy for Hepatitis Is Challenged, St. Louis University Study
December 4, 2008
 · 
1 min read
Drug Development
Blood Pressure Pill Combo More Effective Than Diuretics, University of Michigan Health System Study
December 4, 2008
 · 
1 min read
Drug Development
Allergic Reactions To Gardasil Uncommon, Royal Children’s Hospital Study
December 3, 2008
 · 
1 min read
Drug Development
ADHD Medications Do Not Cause Genetic Damage In Children, National Institutes of Health (NIH) And Duke University Medical Center Study Shows
November 20, 2008
 · 
5 min read
Drug Development
Spinal Anesthesia Doesn’t Cause Restless Leg Syndrome, University of Gottingen Medical School Study
November 20, 2008
 · 
1 min read
Load More
PRESS RELEASES
Drug Development
Pfizer Reports Top-Line Results From A Phase 4 Study Evaluating LYRICA® Capsules CV As A Treatment For Adolescents With Fibromyalgia
March 13, 2015
 · 
7 min read
Drug Development
Trevi Therapeutics Announces Initiation Of A Pivotal Study Of Nalbuphine ER In Prurigo Nodularis
March 11, 2015
 · 
3 min read
Drug Development
Merck & Co. Release: Two New Post-Hoc Analyses Of TRA 2°P TIMI 50 Study Showed ZONTIVITY (Vorapaxar) Added To Aspirin And/Or Clopidogrel Reduced Acute Limb Ischemia And Peripheral Revascularizations, Respectively, In Certain Patients With Peripheral Arter
March 5, 2015
 · 
14 min read
Drug Development
Merck & Co. Release: New Data From IMPROVE-IT Study Of VYTORIN® (Ezetimibe/Simvastatin) And TRA 2ºp TIMI 50 Study Of ZONTIVITY® (Vorapaxar) To Be Presented At American College of Cardiology Scientific Sessions
February 25, 2015
 · 
19 min read
Drug Development
Celltrion Healthcare: Data Show The World’s First European Medicines Agency-Approved Biosimilar Monoclonal Antibody Remsima Could Reduce Cost Of Treating Crohn’s Disease By Up To €336 Million Over Five Years
February 20, 2015
 · 
4 min read
Drug Development
Regeneron Release: NIH-Sponsored Comparative Effectiveness Trial In Diabetic Macular Edema Shows EYLEA (Aflibercept) Injection Demonstrated Significantly Greater Gains In Visual Acuity Than Both Bevacizumab And Ranibizumab
February 19, 2015
 · 
13 min read
Drug Development
Cumberland Pharmaceuticals Release: Phase IV Studies Published Supporting The Safety Of A Shortened Infusion Time Of Caldolor® (ibuprofen) Injection
February 2, 2015
 · 
3 min read
Drug Development
AstraZeneca PLC’s Brilinta Boosted by Major Clinical Trial Success
January 14, 2015
 · 
9 min read
Drug Development
Ipsen To Present Further Data On Recently FDA-Approved Antitumor Therapy, Somatuline® Depot® (Lanreotide), At Gastrointestinal Cancers Symposium
January 13, 2015
 · 
1 min read
Drug Development
DBV Technologies Announces Publication In The Journal Of Allergy And Clinical Immunology Of Data Demonstrating That Epicutaneous Immunotherapy May Influence The Natural History Of Allergy
January 12, 2015
 · 
5 min read
Drug Development
Merck & Co.'s Gardasil Not Linked To Multiple Sclerosis, JAMA Reveals
January 7, 2015
 · 
2 min read
Drug Development
Cerulean Pharma Inc. Announces Publication Describing Synergistic Anti-Tumor Activity Of CRLX101 With Avastin In Advanced Metastatic Ovarian Tumor Models
January 6, 2015
 · 
6 min read
Drug Development
Soligenix Announces Publication of Combination Ricin/Anthrax Vaccine Data
December 29, 2014
 · 
13 min read
Drug Development
Genentech Provides Update On Phase 3 MARIANNE Study In People With Previously Untreated Advanced HER2-Positive Breast Cancer
December 19, 2014
 · 
11 min read
Drug Development
Merck & Co.'s Keytruda Shrank Tumors In Hard-To-Treat Breast Cancer Patients
December 10, 2014
 · 
14 min read
Drug Development
Hemispherx Biopharma Announces Data Showing Inhibition Of Ebola By Ampligen® Enlarged By Howard University Research
December 9, 2014
 · 
9 min read
Drug Development
Gilead Sciences, Inc. Presents Follow-Up Data From Zydelig Registrational Studies In Patients With Chronic Lymphocytic Leukemia, Follicular Lymphoma And Small Lymphocytic Lymphoma
December 8, 2014
 · 
11 min read
Drug Development
Amgen And Onyx Pharmaceuticals, Inc. Announce Detailed Results From Phase 3 ASPIRE Study Of Kyprolis® (Carfilzomib) In Patients With Relapsed Multiple Myeloma
December 8, 2014
 · 
18 min read
Drug Development
Amgen’s Kyprolis Delivers In Phase 3 Multiple Myeloma Study
December 8, 2014
 · 
18 min read
Drug Development
Merck & Co.'s Vytorin Proves Effective; IMPROVE-IT Trial Achieves Primary Endpoint
November 17, 2014
 · 
17 min read
Load More